{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T09:46:19Z","timestamp":1769075179424,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bioenerg Biomembr"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s10863-018-9746-z","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T21:35:32Z","timestamp":1519335332000},"page":"81-91","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Searching for new drugs for Chagas diseases: triazole analogs display high in vitro activity against Trypanosoma cruzi and low toxicity toward mammalian cells"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8218-834X","authenticated-orcid":false,"given":"Robson Xavier","family":"Faria","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Tadeu Gomes","family":"Gonzaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Anast\u00e1cio Furtado","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 Luis Almeida","family":"Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor Francisco","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando de Carvalho","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"9746_CR1","doi-asserted-by":"publisher","first-page":"6815","DOI":"10.1016\/j.bmc.2015.10.008","volume":"23","author":"P Andrade","year":"2015","unstructured":"Andrade P, Galo OA, Carvalho MR, Lopes CD, Carneiro ZA, Sesti-Costa R, de Melo EB, Silva JS, Carvalho I (2015) 1,2,3-Triazole-based analogue of benzonidazole displays remarkable activity against Trypanosoma cruzi. Bioorg Med Chem 23:6815\u20136826. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2015.10.008","journal-title":"Bioorg Med Chem"},{"key":"9746_CR2","doi-asserted-by":"publisher","first-page":"e1870","DOI":"10.1371\/journal.pntd.0001870","volume":"6","author":"MT Bahia","year":"2012","unstructured":"Bahia MT, Andrade IM, Martins TAF, Nascimento AFS, Diniz LF, Caldas IS, Talvani A, Trunz BB, Torreele E, Ribeiro I (2012) Fexinidazole: a potential new drug candidate for Chagas disease. PLoS Negl Trop Dis 6:e1870. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0001870","journal-title":"PLoS Negl Trop Dis"},{"key":"9746_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exppara.2012.02.028","volume":"131","author":"MC Becerra","year":"2012","unstructured":"Becerra MC, Gui\u00f1az\u00fa N, Hergert LY, Pellegrini A, Mazzieri MR, Gea S, Albesa I (2012) In vitro activity of N-benzenesulfonylbenzotriazole on Trypanosoma cruzi epimastigote and trypomastigote forms. Exp Parasitol 131:57\u201362. \n                    https:\/\/doi.org\/10.1016\/j.exppara.2012.02.028","journal-title":"Exp Parasitol"},{"key":"9746_CR4","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1086\/605091","volume":"49","author":"C Bern","year":"2009","unstructured":"Bern C, Montgomery SP (2009) An estimate of the burden of Chagas disease in the United States. Clin Infect Dis 49:e52\u2013e54. \n                    https:\/\/doi.org\/10.1086\/605091","journal-title":"Clin Infect Dis"},{"key":"9746_CR5","doi-asserted-by":"publisher","first-page":"5988","DOI":"10.1021\/jm2003624","volume":"54","author":"N Boechat","year":"2011","unstructured":"Boechat N, Ferreira VF, Ferreira SB, de Lourdes G, Ferreira M, de C da Silva F, Bastos MM, Dos S Costa M, Louren\u00e7o MC, Pinto AC, Krettli AU, Aguiar AC, Teixeira BM, da Silva NV, Martins PR, Bezerra FA, Camilo AL, da Silva GP, Costa CC (2011) Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (atccATCC 27294) strain. J Med Chem 54:5988\u20135999. \n                    https:\/\/doi.org\/10.1021\/jm2003624","journal-title":"J Med Chem"},{"key":"9746_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1749-6632.1988.tb40391.x","volume":"544","author":"FT Boyle","year":"1988","unstructured":"Boyle FT, Gilman DJ, Gravestock MB, Wardleworth JM (1988) Synthesis and structure-activity relationships of a novel antifungal agent ICI 195,739. Ann N Y Acad Sci 544:86\u2013100. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1988.tb40391.x","journal-title":"Ann N Y Acad Sci"},{"key":"9746_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-12-385863-4.00005-8","volume":"75","author":"FS Buckner","year":"2011","unstructured":"Buckner FS (2011) Experimental chemotherapy and approaches to drug discovery for Trypanosoma cruzi infection. Adv Parasitol 75:89\u2013119. \n                    https:\/\/doi.org\/10.1016\/B978-0-12-385863-4.00005-8","journal-title":"Adv Parasitol"},{"key":"9746_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijpddr.2012.05.002","volume":"2","author":"FS Buckner","year":"2012","unstructured":"Buckner FS, Waters NC, Avery VM (2012) Recent highlights in anti-protozoan drug development and resistance research. Int J Parasitol Drugs Drug Resist 2:230\u2013235. \n                    https:\/\/doi.org\/10.1016\/j.ijpddr.2012.05.002","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"9746_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/infdis\/jit420","volume":"209","author":"JM Bustamante","year":"2013","unstructured":"Bustamante JM, Craft JM, Crowe BD, Ketchie SA, Tarleton RL (2013) New, combined, and reduced dosing treatment protocols cure Trypanosoma cruzi infection in mice. J Infect Dis 209:150\u2013162. \n                    https:\/\/doi.org\/10.1093\/infdis\/jit420","journal-title":"J Infect Dis"},{"key":"9746_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1590\/S0037-86822003000200002","volume":"36","author":"EL Camandaroba","year":"2003","unstructured":"Camandaroba EL, Reis EA, Gon\u00e7alves MS, Reis MG, Andrade SG (2003) Trypanosoma cruzi: susceptibility to chemotherapy with benzonidazole of clones isolated from the highly resistant Colombian strain. Rev Soc Bras Med Trop 36:201\u2013209. \n                    https:\/\/doi.org\/10.1590\/S0037-86822003000200002","journal-title":"Rev Soc Bras Med Trop"},{"key":"9746_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1590\/0074-0276140497","volume":"109","author":"AS Carvalho","year":"2014","unstructured":"Carvalho AS, Salom\u00e3o K, Castro SL, Conde TR, Zamith HP, Caffarena ER, Hall BS, Wilkinson SR, Boechat N (2014) Megazol and its bioisostere 4H-1,2,4-triazole: comparing the trypanocidal, cytotoxic and genotoxic activities and their in vitro and in silico interactions with the Trypanosoma brucei nitroreductase enzyme. Mem Inst Oswaldo Cruz 109:315\u2013323. \n                    https:\/\/doi.org\/10.1590\/0074-0276140497","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"9746_CR12","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1128\/AAC.49.4.1556-1560.2005","volume":"49","author":"M Corrales","year":"2005","unstructured":"Corrales M, Cardozo R, Segura MA, Urbina JA, Basombr\u00edo MA (2005) Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benzonidazole in preventing cardiac damage in a murine model of Chagas' disease. Antimicrob Agents Chemother 49:1556\u20131560. \n                    https:\/\/doi.org\/10.1128\/AAC.49.4.1556-1560.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"9746_CR13","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ejmech.2012.03.039","volume":"52","author":"EN Silva J\u00fanior da","year":"2012","unstructured":"da Silva J\u00fanior EN, de Melo IM, Diogo EB, Costa VA, de Souza Filho JD, Valen\u00e7a WO, Camara CA, de Oliveira RN, de Araujo AS, Emery FS, dos Santos MR, de Simone CA, Menna-Barreto RF, de Castro SL (2012) On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions. Eur J Med Chem 52:304\u2013312. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2012.03.039","journal-title":"Eur J Med Chem"},{"key":"9746_CR14","doi-asserted-by":"publisher","first-page":"e1342","DOI":"10.3390\/molecules21101342","volume":"21","author":"PR Elias","year":"2016","unstructured":"Elias PR, Coelho GS, Xavier VF, Sales Junior PA, Romanha AJ, Murta SM, Carneiro CM, Camilo NS, Hil\u00e1rio FF, Taylor JG (2016) Synthesis of Xylitan derivatives and preliminary evaluation of in vitro Trypanocidal activity. Molecules 21:e1342. \n                    https:\/\/doi.org\/10.3390\/molecules21101342","journal-title":"Molecules"},{"key":"9746_CR15","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1128\/AAC.01170-06","volume":"51","author":"ML Ferraz","year":"2007","unstructured":"Ferraz ML, Gazzinelli RT, Alves RO, Urbina JA, Romanha AJ (2007) The anti-Trypanosoma cruzi activity of posaconazole in a murine model of acute Chagas\u2019 disease is less dependent on gamma interferon than that of benzonidazole. Antimicrob Agents Chemother 51:1359\u20131364. \n                    https:\/\/doi.org\/10.1128\/AAC.01170-06","journal-title":"Antimicrob Agents Chemother"},{"key":"9746_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","volume":"15","author":"MC Field","year":"2017","unstructured":"Field MC, Horn D, Fairlamb AH, Ferguson MAJ, Gray DW, Read KD, De Rycker M, Torrie LS, Wyatt PG, Wyllie S, Gilbert IH (2017) Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need. Nat Rev Microbiol 15:217\u2013231. \n                    https:\/\/doi.org\/10.1038\/nrmicro.2017.69","journal-title":"Nat Rev Microbiol"},{"key":"9746_CR17","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/0035-9203(87)90020-4","volume":"81","author":"LS Filardi","year":"1987","unstructured":"Filardi LS, Brener Z (1987) Susceptibility and natural resistance of Trypanosoma cruzistrains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 81:755\u2013759","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"9746_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.actatropica.2009.07.019","volume":"115","author":"J Gascon","year":"2010","unstructured":"Gascon J, Bern C, Pinazo MJ (2010) Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop 115:22\u201327. \n                    https:\/\/doi.org\/10.1016\/j.actatropica.2009.07.019","journal-title":"Acta Trop"},{"key":"9746_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0166-6851(89)90069-8","volume":"32","author":"LJ Goad","year":"1989","unstructured":"Goad LJ, Berens RL, Marr JJ, Beach DH, Holz GG Jr (1989) The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro. Mol Biochem Parasitol 32:179\u2013190","journal-title":"Mol Biochem Parasitol"},{"key":"9746_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ejmech.2013.12.039","volume":"74","author":"D Gonzaga","year":"2014","unstructured":"Gonzaga D, Senger MR, da Silva FC, Ferreira VF, Silva FP Jr (2014) 1-phenyl-1H- and 2-phenyl-2H-1,2,3-triazol derivatives: design, synthesis and inhibitory effect on alpha-glycosidases. Eur J Med Chem 74:461\u2013476. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2013.12.039","journal-title":"Eur J Med Chem"},{"key":"9746_CR21","doi-asserted-by":"publisher","first-page":"4286","DOI":"10.1128\/AAC.48.11.4286-4292.2004","volume":"48","author":"PM Guedes","year":"2004","unstructured":"Guedes PM, Urbina JA, de Lana M, Afonso LC, Veloso VM, Tafuri WL, Machado-Coelho GL, Chiari E, Bahia MT (2004) Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts. Antimicrob Agents Chemother 48:4286\u20134292. \n                    https:\/\/doi.org\/10.1128\/AAC.48.11.4286-4292.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"9746_CR22","doi-asserted-by":"publisher","first-page":"10158","DOI":"10.1021\/jm401610c","volume":"56","author":"M Keenan","year":"2013","unstructured":"Keenan M, Chaplin JH, Alexander PW, Abbott MJ, Best WM, Khong A, Botero A, Perez C, Cornwall S, Thompson RA, White KL, Shackleford DM, Koltun M, Chiu FC, Morizzi J, Ryan E, Campbell M, von Geldern TW, Scandale I, Chatelain E, Charman SA (2013) Two analogues of fenarimol show curative activity in an experimental model of Chagas disease. J Med Chem 56:10158\u201310170. \n                    https:\/\/doi.org\/10.1021\/jm401610c","journal-title":"J Med Chem"},{"key":"9746_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1590\/S0036-46652009000500011","volume":"51","author":"AT Kinoshita-Yanaga","year":"2009","unstructured":"Kinoshita-Yanaga AT, Toledo MJ, Ara\u00fajo SM, Vier BP, Gomes ML (2009) Accidental infection by Trypanosoma cruzi follow-up by polymerase chain reaction: case report. Rev Inst Med Trop S\u00e3o Paulo 51:295\u2013298. \n                    https:\/\/doi.org\/10.1590\/S0036-46652009000500011","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"9746_CR24","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","volume":"40","author":"HC Kolb","year":"2001","unstructured":"Kolb HC, Finn MG, Sharpless KB (2001) Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed Engl 40:2004\u20132021. \n                    https:\/\/doi.org\/10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","journal-title":"Angew Chem Int Ed Engl"},{"issue":"8","key":"9746_CR25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1517\/14656566.8.8.1167","volume":"8","author":"DS Kwon","year":"2007","unstructured":"Kwon DS, Mylonakis E (2007) Posaconazole: a new broad-spectrum antifungal agent. Expert Opin Pharmacother 8(8):1167\u20131178","journal-title":"Expert Opin Pharmacother"},{"key":"9746_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/jac\/41.2.197","volume":"41","author":"A Liendo","year":"1998","unstructured":"Liendo A, Lazardi K, Urbina JA (1998) In-vitro antiproliferative effects and mechanism of action of the bis-triazole D0870 and its S(\u2212) enantiomer against Trypanosoma cruzi. J Antimicrob Chemother 41:197\u2013205","journal-title":"J Antimicrob Chemother"},{"key":"9746_CR27","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4269\/ajtmh.1986.35.280","volume":"35","author":"RE McCabe","year":"1986","unstructured":"McCabe RE, Remington JS, Araujo FG (1986) In vitro and in vivo effects of itraconazole against Trypanosoma cruzi. Am J Trop Med Hyg 35:280\u2013284. \n                    https:\/\/doi.org\/10.4269\/ajtmh.1986.35.280","journal-title":"Am J Trop Med Hyg"},{"key":"9746_CR28","doi-asserted-by":"publisher","first-page":"150\u00ad155","DOI":"10.1128\/AAC.44.1.150-155.2000","volume":"44","author":"J Molina","year":"2000","unstructured":"Molina J, Martins-Filho O, Brener Z, Romanha AJ, Loebenberg D, Urbina JA (2000a) Activities of the triazole derivative SCH 56592 (posaconazole) against drug\u00adresistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts. Antimicrob Agents Chemother 44:150\u00ad155. \n                    https:\/\/doi.org\/10.1128\/AAC.44.1.150-155.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"9746_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jac\/46.1.137","volume":"46","author":"J Molina","year":"2000","unstructured":"Molina J, Brener Z, Romanha AJ, Urbina JA (2000b) In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi. J Antimicrob Chemother 46:137\u2013140","journal-title":"J Antimicrob Chemother"},{"key":"9746_CR30","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","volume":"370","author":"I Molina","year":"2014","unstructured":"Molina I, G\u00f3mez i Prat J, Salvador F, Trevi\u00f1o B, Sulleiro E, Serre N, Pou D, Roure S, Cabezos J, Valerio L, Blanco-Grau A, S\u00e1nchez-Montalv\u00e1 A, Vidal X, Pahissa A (2014) Randomized trial of Posaconazole and Benzonidazole for chronic Chagas\u2019 disease. N Engl J Med 370:1899\u201319008. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1313122","journal-title":"N Engl J Med"},{"key":"9746_CR31","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/srep04703","volume":"4","author":"CB Moraes","year":"2014","unstructured":"Moraes CB, Giardini MA, Kim H, Franco CH, Araujo-Junior AM, Schenkman S, Chatelain E, Freitas-Junior LH (2014) Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development. Sci Rep 4:4703. \n                    https:\/\/doi.org\/10.1038\/srep04703","journal-title":"Sci Rep"},{"key":"9746_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1021\/jm00226a013","volume":"19","author":"T Novinsion","year":"1976","unstructured":"Novinsion T, Bhooshan B, Okabe T, Revankar GR, Robins RK, Senga K, Wilson HR (1976) Novel heterocyclic nitrofurfural hydrazones. In vivo antitrypanosomal activity. J Med Chem 19:512\u2013516. \n                    https:\/\/doi.org\/10.1021\/jm00226a013","journal-title":"J Med Chem"},{"key":"9746_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijantimicag.2010.03.006","volume":"36","author":"BP Olivieri","year":"2010","unstructured":"Olivieri BP, Molina JT, de Castro SL, Pereira MC, Calvet CM, Urbina JA, Ara\u00fajo-Jorge TC (2010) A comparative study of posaconazole and benzonidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease. Int J Antimicrob Agents 36:79\u201383. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2010.03.006","journal-title":"Int J Antimicrob Agents"},{"key":"9746_CR34","doi-asserted-by":"publisher","first-page":"6600","DOI":"10.1016\/j.bmc.2013.08.022","volume":"21","author":"MV Papadopoulou","year":"2013","unstructured":"Papadopoulou MV, Bloomer WD, Rosenzweig HS, Kaiser M, Chatelain E, Ioset JR (2013a) Novel 3-nitro-1H-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents. Bioorg Med Chem 21:6600\u20136607. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2013.08.022","journal-title":"Bioorg Med Chem"},{"key":"9746_CR35","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.4155\/fmc.13.108","volume":"5","author":"MV Papadopoulou","year":"2013","unstructured":"Papadopoulou MV, Bloomer WD, Rosenzweig HS, Ashworth R, Wilkinson SR, Kaiser M, Andriani G, Rodriguez A (2013b) Novel 3-nitro-1H-1,2,4-triazole-based compounds as potential anti-Chagasic drugs: in vivo studies. Future Med Chem 5:1763\u20131776. \n                    https:\/\/doi.org\/10.4155\/fmc.13.108","journal-title":"Future Med Chem"},{"key":"9746_CR36","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.3390\/molecules22030369","volume":"22","author":"MW Pertino","year":"2017","unstructured":"Pertino MW, Vega C, Rol\u00f3n M, Coronel C, Rojas de Arias A, Schmeda-Hirschmann G (2017) Antiprotozoal activity of Triazole derivatives of Dehydroabietic acid and Oleanolic acid. Molecules 22:e369. \n                    https:\/\/doi.org\/10.3390\/molecules22030369","journal-title":"Molecules"},{"key":"9746_CR37","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1749-6632.1988.tb40385.x","volume":"544","author":"K Richardson","year":"1988","unstructured":"Richardson K, Cooper K, Marriott MS, Tarbit MH, Troke PF, Whittle PJ (1988) Design and evaluation of a systemic active agent, fluconazole. Ann N Y Acad Sci 544:4\u201311. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1988.tb40385.x","journal-title":"Ann N Y Acad Sci"},{"key":"9746_CR38","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1749-6632.1988.tb40416.x","volume":"544","author":"JF Ryley","year":"1988","unstructured":"Ryley JF, McGregor S, Wilson RG (1988) Activity of ICI 195,739-a novel, orally active bistriazole-in rodent models of fungal and protozoal infections. Ann N Y Acad Sci 544:310\u2013328. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1988.tb40416.x","journal-title":"Ann N Y Acad Sci"},{"key":"9746_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ejmech.2016.04.065","volume":"121","author":"FT Silva","year":"2016","unstructured":"Silva FT, Franco CH, Favaro DC, Freitas-Junior LH, Moraes CB, Ferreira EI (2016) Design, synthesis and antitrypanosomal activity of some nitrofurazone 1,2,4-t riazolic bioisosteric analogues. Eur J Med Chem 121:553\u2013560. \n                    https:\/\/doi.org\/10.1016\/j.ejmech.2016.04.065","journal-title":"Eur J Med Chem"},{"key":"9746_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/tmi.12014","volume":"18","author":"AP Teston","year":"2013","unstructured":"Teston AP, Monteiro WM, Reis D, Bossolani GD, Gomes ML, de Ara\u00fajo SM, Bahia MT, Barbosa MG, Toledo MJ (2013) In vivo susceptibility to benzonidazole of Trypanosoma cruzi strains from the western Brazilian Amazon. Tropical Med Int Health 18:85\u201395. \n                    https:\/\/doi.org\/10.1111\/tmi.12014","journal-title":"Tropical Med Int Health"},{"key":"9746_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1749-6632.1988.tb40414.x","volume":"544","author":"PF Troke","year":"1988","unstructured":"Troke PF, Marriott MS, Richardson K, Tarbit MH (1988) In vitro potency and in vivo activity of azoles. Ann N Y Acad Sci 544:284\u2013293. \n                    https:\/\/doi.org\/10.1111\/j.1749-6632.1988.tb40414.x","journal-title":"Ann N Y Acad Sci"},{"key":"9746_CR42","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1128\/AAC.35.4.730","volume":"35","author":"JA Urbina","year":"1991","unstructured":"Urbina JA, Lazardi K, Aguirre T, Piras MM, Piras R (1991) Antiproliferative effects and mechanism of action of ICI 195,739, a novel Bis-Triazole derivative, on Epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 35:730\u2013735. \n                    https:\/\/doi.org\/10.1128\/AAC.35.4.730","journal-title":"Antimicrob Agents Chemother"},{"key":"9746_CR43","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/AAC.42.7.1771","volume":"42","author":"JA Urbina","year":"1998","unstructured":"Urbina JA, Payares G, Contreras LM, Liendo A, Sanoja C, Molina J, Piras M, Piras R, Perez N, Wincker P, Loebenberg D (1998) Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother 42:1771\u20131177","journal-title":"Antimicrob Agents Chemother"},{"key":"9746_CR44","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1128\/AAC.44.9.2498-2502.2000","volume":"44","author":"JA Urbina","year":"2000","unstructured":"Urbina JA, Lira R, Visbal G, Bartrol\u00ed J (2000) In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi. Antimicrob Agents Chemother 44:2498\u20132502. \n                    https:\/\/doi.org\/10.1128\/AAC.44.9.2498-2502.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"9746_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0924-8579(02)00274-1","volume":"21","author":"JA Urbina","year":"2003","unstructured":"Urbina JA, Payares G, Sanoja C, Molina J, Lira R, Brener Z, Romanha AJ (2003a) Parasitological cure of acute and chronic experimental Chagas disease using the long-acting experimental triazole TAK-187. Activity against drug-resistant Trypanosoma cruzi strains. Int J Antimicrob Agents 21:39\u201348. \n                    https:\/\/doi.org\/10.1016\/S0924-8579(02)00274-1","journal-title":"Int J Antimicrob Agents"},{"key":"9746_CR46","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0924-8579(02)00273-X","volume":"21","author":"JA Urbina","year":"2003","unstructured":"Urbina JA, Payares G, Sanoja C, Lira R, Romanha AJ (2003b) In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease. Int J Antimicrob Agents 21:27\u201338. \n                    https:\/\/doi.org\/10.1016\/S0924-8579(02)00273-X","journal-title":"Int J Antimicrob Agents"},{"key":"9746_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/ps.2780210406","volume":"21","author":"H Bossche Van den","year":"1987","unstructured":"Van den Bossche H, Marichal P, Gorrens J, Bellens D, Verhoeven H, Coene MC, Lauwers W, Janssen PAJ (1987) Interaction of azole derivatives with cytochrome P-450 isoenzymes in yeast, fungi, plants and mammalian cells. Pest Manag Sci 21:289\u2013306. \n                    https:\/\/doi.org\/10.1002\/ps.2780210406","journal-title":"Pest Manag Sci"},{"key":"9746_CR48","doi-asserted-by":"publisher","unstructured":"Van den Bossche H, Marichal P, Geerts H, Janssen PAJ (1988) The molecular basis of itraconazole's activity against aspergillus fumigatus. In: Vanden Bossche H, Mackenzie DWR, Cauwenbergh G (eds) Aspergillus and aspergillosis, springer, Boston, pp 171\u2013197. \n                    https:\/\/doi.org\/10.1007\/978-1-4899-3505-2_17","DOI":"10.1007\/978-1-4899-3505-2_17"},{"issue":"1","key":"9746_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijantimicag.2012.03.009","volume":"40","author":"P Veiga-Santos","year":"2012","unstructured":"Veiga-Santos P, Barrias ES, Santos JF, de Barros Moreira TL, de Carvalho TM, Urbina JA, de Souza W (2012) Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents 40(1):61\u201371. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.03.009","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"9746_CR50","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1590\/S0074-02762009000700021","volume":"104","author":"B Zingales","year":"2009","unstructured":"Zingales B, Andrade SG, Briones MR, Campbell DA, Chiari E, Fernandes O, Guhl F, Lages-Silva E, Macedo AM, Machado CR, Miles MA, Romanha AJ, Sturm NR, Tibayrenc M, Schijman AG; Second Satellite Meeting (2009) A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 104(7):1051\u20131054","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Journal of Bioenergetics and Biomembranes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10863-018-9746-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-018-9746-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10863-018-9746-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T20:12:00Z","timestamp":1550866320000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10863-018-9746-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["9746"],"URL":"https:\/\/doi.org\/10.1007\/s10863-018-9746-z","relation":{},"ISSN":["0145-479X","1573-6881"],"issn-type":[{"value":"0145-479X","type":"print"},{"value":"1573-6881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,23]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author(s) declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}]}}